翻訳と辞書 |
fosaprepitant : ウィキペディア英語版 | fosaprepitant
Fosaprepitant (Emend for Injection (US), Ivemend (EU)) is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved by the United States Food and Drug Administration (FDA) on January 25, 2008〔(【引用サイトリンク】title=Drugs.com, FDA Approves Emend (fosaprepitant dimeglumine) for Injection, Merck's New Intravenous Therapy, for Use in Combination with Other Antiemetics for Prevention of Nausea and Vomiting Caused by Chemotherapy )〕 and by the European Medicines Agency (EMA) on January 11 of the same year.〔(【引用サイトリンク】title=European Public Assessment Report for Ivemend (from the EMEA website) )〕 == See also ==
* Aprepitant * Casopitant * L-733,060 * Maropitant * Vestipitant
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「fosaprepitant」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|